A study showed that a FAT1 defect can lead to a reduction in cell migration and cell–cell adhesion, FSGS due to podocyte-specific FAT1 loss-of-function, and CDC42-mediated renal tubular defects due to FAT1 loss. This evidence concerns the gene CDC42 and focal segmental glomerulosclerosis.